Medtronic MiniMed(TM) Pro-set(TM) (MMT-280, 281)
Published November 29, 2017 · Recall initiated: September 10, 2017
Summary
FDA records medical device Class II recall Z-0111-2018, published November 29, 2017 and initiated September 10, 2017. Recalling firm: Medtronic Inc.; Status: Ongoing; Reported quantity: 5,842 units; Lot: Lot Numbers: 6211649, 6207537. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Medtronic MiniMed(TM) Infusion Sets have the potential for over-delivery of Insulin.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Medtronic Inc.
- Distributor
- Worldwide
- Lot
- Lot Numbers: 6211649, 6207537
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA2090 Programmers with serial number prefixes PKK0 and PKK1: a) 2090, Product Description: PRGM 2090September 25, 2024
- FDACobalt XT DR MRI SureScan, Model Number DDPA2D1, Implantable Cardioverter DefibrillatorJuly 3, 2024
- FDACOBALT XT VR MRI SureScan, Model Number DVPA2D1, Implantable Cardioverter DefibrillatorJuly 3, 2024
- FDAMIRRO MRI VR SureScan, Model Number DVME3D4, Implantable Cardioverter DefibrillatorJuly 3, 2024
- FDASURPLUG MICRO CONNECTOR Item No. 066-C3352; 111" (282 cm) Appx 13.9 ml, 15 Drop Admin Set w/3-Way Stopcock, 1November 29, 2017
- FDA3M Bair Hugger(TM) Normothermia System, Temperature Monitoring System Sensors Model 360 (Part Number 36000)November 29, 2017
Questions about this recall
Was Medtronic MiniMed(TM) Pro-set(TM) (MMT-280, 281) recalled?
Yes. FDA published recall Z-0111-2018 on November 29, 2017. Reported hazard: Medtronic MiniMed(TM) Infusion Sets have the potential for over-delivery of Insulin.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release